Is Novavax stock a buy right now?
Why is Novavax price dropping?
Novavax (NVAX) shares were plunging more than 15% on February 8, 2022), at $80.13. The shares are down 43% so far this year and 74% over the past 12 months. According to the new report from Reuters, shipments Novavax expected to deliver in the first quarter are now delayed. Novavax acknowledged to Reuters that it had only delivered 10 million doses, and said that shipments had been delayed by regulatory processes. It said that in some cases, doses are sitting in distribution centers, ready to be sent out.
Is Novavax stock going up?
Novavax was an early favorite in the coronavirus vaccine race but fell behind last year.
Is Novavax stock a good investment?
Novavax is reaching the coronavirus vaccine market about a year after market leaders. So, investors are concerned Novavax might be arriving at a point when demand for vaccination may significantly drop. The company has reported years of annual losses. This is a common trait for newly commercial biotech companies — which are usually investing in research and development.
Vaccine leaders Pfizer and Moderna both have suggested that an annual vaccine or booster will be needed. This means vaccines should continue to generate revenue in a post-pandemic world. It's clear that Novavax's opportunity would have been even greater if it had entered the vaccine market at the same time as Pfizer and Moderna. But that doesn't mean opportunity has evaporated.
In the last 5 years Novavax saw its revenue grow at 83% per year. So it's not entirely surprising that the share price reflected this performance by increasing at a rate of 28% per year, in that time. This mean, longer term investors would have made 28%, each year over five years.
Still, Novavax stock remains a speculative investment and carry higher risks for investors. This stock is best for investors who can tolerate volatility and risk.
Is Novavax a good buy right now?
Now, the question is whether, after that decline, this vaccine latecomer is a buy right now. On a fundamental level, NVAX stock is plagued by years of losses and its revenue remains low. So, Novavax stock remains a speculative investment and carry higher risks for investors. This stock is best for investors who can tolerate volatility and risk.
How do I buy stocks on Novavax?
You have two options when it comes to buying Novavax shares – investing in the stock outright and trading its share price. Investing in Novavax shares means you’re buying physical shares and taking direct ownership of them. You could be eligible to receive dividends if the company grants them, and you’ll also have shareholder voting rights. Trading Novavax stock means you’ll have the opportunity to speculate on both rising and falling share prices without taking ownership of any assets. You’ll ‘go long’ (buy) if you think the share price will rise or ‘go short’ (sell) if you think it’ll fall.
The easiest way for beginners to get started investing in the stock market is to put money in an online investment account. You can buy Novavax (NVAX) stock through an online stockbroker, such as eToro and Robinhood.
